- Exchange: Berlin
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Snapshot for ImmuCell Corp (IUL)
| Open: | 2.728 | Day's Range: | 2.728 - 2.728 | Volume: | 0 |
|---|---|---|---|---|---|
| Previous Close: | 2.819 | 52wk Range: | 2.464 - 5.308 | 1-Yr Rtn: | -41.04% |
Key Statistics for IUL
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. DAX | - |
| Earnings Per Share (ttm) | - |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M EUR) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 0 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/13/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for IUL
Company Profile & Key Executives for IUL
ImmuCell Corporation is a biotechnology company which develops and manufactures milk-derived passive antibody products. The Company's products prevent and/or treat gastrointestinal infections in humans and animals. ImmuCell also, through joint ventures, entered into a UK distribution agreement to market Crypto-Scan, a drinking-water test, and is also manufacturing bovine lactoferrin.
| Michael F BrighamPresident/CEO/Treasurer/Secy | Joseph H CrabbVP/Chief Scientific Officer |
| Bobbi Jo Brockmann "Kunde"Director:Sales & Marketing |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
IUL News
-
Industry News
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page